{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:06:48Z","timestamp":1789574808608,"version":"build-2803163510"},"reference-count":27,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Qual Saf"],"accepted":{"date-parts":[[2026,7,21]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Medication-related problems (MRPs) place a substantial burden on the healthcare system, contributing to hospital admissions and significant healthcare costs. Quality prescribing indicators (QPIs) offer a way to evaluate and guide improvements in prescribing with the aim of improving medicine use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to establish an updated set of QPIs for Australian primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Potential QPIs were identified from a scoping review and reviewed by clinical members of the research team. Potential QPIs (n=37) that were identified to be relevant, feasible and impactful by the research team were assessed by an expert panel using a two-round Delphi consensus-building approach. The panel (n=42) included experienced general practitioners, pharmacists and nurse practitioners from urban\/regional settings across Victoria, New South Wales and Tasmania. Each QPI\u2019s validity and importance were scored on a 5-point Likert scale. Participants could provide comments that were anonymously presented in round 2, along with other participants\u2019 scores. A QPI was approved if &gt;80% of participants scored it a 4 or 5 for both validity and importance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 23 of the 37 selected QPIs were approved, covering proton pump inhibitors, vaccinations, antihypertensives, anti-inflammatories, inhaled corticosteroids, mental health treatments and analgesics. The selected QPIs provide information on appropriate initiation, monitoring, deprescribing and the avoidance of high-risk prescribing. While mean scores and rate of acceptance were high, comments suggested perceived difficulties implementing some of the QPIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>QPIs for primary care were developed after a rigorous review and consensus process. These should be progressed to field testing and implementation. If integrated into routine primary care practice through educational audit and feedback, the QPIs may improve the quality use of medicines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjqs-2026-020441","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:20:12Z","timestamp":1789572012000},"page":"bmjqs-2026-020441","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Establishing quality prescribing indicators for Australian primary care: a Delphi study"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-7586","authenticated-orcid":false,"given":"James","family":"Nind","sequence":"first","affiliation":[{"name":"Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mackintosh","sequence":"additional","affiliation":[{"name":"Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6001-9211","authenticated-orcid":false,"given":"Amanda J","family":"Cross","sequence":"additional","affiliation":[{"name":"Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M","family":"Peterson","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmacology, UTAS Health, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6520-4213","authenticated-orcid":false,"given":"Constance Dimity","family":"Pond","sequence":"additional","affiliation":[{"name":"University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3747-0087","authenticated-orcid":false,"given":"Elizabeth","family":"Manias","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandana","family":"Saini","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Radford","sequence":"additional","affiliation":[{"name":"Launceston Clinical School, Tasmanian School of Medicine, UTAS Health, University of Tasmania, Launceston, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnson","family":"George","sequence":"additional","affiliation":[{"name":"Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"2026091608200435000_bmjqs-2026-020441v1.1","unstructured":"WHO Global Patient Safety Challenge . Medication without harm. World Health Organization; 2017."},{"key":"2026091608200435000_bmjqs-2026-020441v1.2","unstructured":"Australian Commission on Safety and Quality in Health Care and NSW Therapeutic Advisory Group Inc . National quality use of medicines indicators for australian hospitals. In: ACSQHC. Sydney, 2014."},{"key":"2026091608200435000_bmjqs-2026-020441v1.3","unstructured":"Duerden M , Millson D , Avery A , et al . The Quality of GP Prescribing. London: The King\u2019s Fund, 2011."},{"key":"2026091608200435000_bmjqs-2026-020441v1.4","doi-asserted-by":"crossref","unstructured":"Tadrous M , Liu S , Tsuyuki RT . Why Pharmacy Practice Needs Quality Indicators? Los Angeles, CA: SAGE Publications Sage CA, 2025:331\u20137.","DOI":"10.1177\/17151635251384474"},{"key":"2026091608200435000_bmjqs-2026-020441v1.5","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12087"},{"key":"2026091608200435000_bmjqs-2026-020441v1.6","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/bcp.70591","article-title":"A scoping review of quality prescribing indicators, rules and criteria for primary care","volume":"92","author":"Nind","year":"2026","journal-title":"Br J Clin Pharmacol"},{"key":"2026091608200435000_bmjqs-2026-020441v1.7","doi-asserted-by":"crossref","DOI":"10.1177\/2042098619829431","article-title":"Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences","volume":"10","author":"Curtin","year":"2019","journal-title":"Ther Adv Drug Saf"},{"key":"2026091608200435000_bmjqs-2026-020441v1.8","unstructured":"NHS Improvement . Quality and outcomes framework guidance for 2023\/24. 2023. Available: https:\/\/www.england.nhs.uk\/long-read\/quality-and-outcomes-framework-guidance-for-2023-24\/ [Accessed 13 Oct 2025]."},{"key":"2026091608200435000_bmjqs-2026-020441v1.9","doi-asserted-by":"publisher","DOI":"10.1080\/02813430902992215"},{"key":"2026091608200435000_bmjqs-2026-020441v1.10","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18372"},{"key":"2026091608200435000_bmjqs-2026-020441v1.11","unstructured":"National Prescribing Service . Indicators of quality prescribing in australian general practice: a manual for users: February 2006. 2006."},{"key":"2026091608200435000_bmjqs-2026-020441v1.12","unstructured":"NPS Medicinewise . Statement on transitioning of NPS medicinewise programs and services. 2022. Available: https:\/\/www.nps.org.au\/media\/statement-on-transitioning-of-nps-medicinewise-programs-and-services [Accessed 04 Mar 2026]."},{"key":"2026091608200435000_bmjqs-2026-020441v1.13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1071\/PY19060","article-title":"Updating and validating quality prescribing indicators for use in Australian general practice","volume":"26","author":"Dang","year":"2019","journal-title":"Aust J Prim Health"},{"key":"2026091608200435000_bmjqs-2026-020441v1.14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/imj.16322","article-title":"Development of a list of Australian potentially inappropriate medicines using the Delphi technique","volume":"54","author":"Wang","year":"2024","journal-title":"Intern Med J"},{"key":"2026091608200435000_bmjqs-2026-020441v1.15","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v11.i4.116"},{"key":"2026091608200435000_bmjqs-2026-020441v1.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304651","article-title":"Delphi studies in social and health sciences-Recommendations for an interdisciplinary standardized reporting (DELPHISTAR). Results of a Delphi study","volume":"19","author":"Niederberger","year":"2024","journal-title":"PLoS ONE"},{"key":"2026091608200435000_bmjqs-2026-020441v1.17","unstructured":"Pharmaceutical Society of Australia . Guidelines for Comprehensive Medication Management Reviews. Canberra: Pharmaceutical Society of Australia Ltd, 2020."},{"key":"2026091608200435000_bmjqs-2026-020441v1.18","unstructured":"Department of Health and Aged Care . Nurse Practitioner Workforce Plan. Canberra: Australian Government, 2023."},{"key":"2026091608200435000_bmjqs-2026-020441v1.19","doi-asserted-by":"crossref","first-page":"112262","DOI":"10.1016\/j.jclinepi.2026.112262","article-title":"Sample size and consensus methods used in Delphi studies are heterogeneous: meta-research study","volume":"195","author":"\u0160krinjar","year":"2026","journal-title":"J Clin Epidemiol"},{"key":"2026091608200435000_bmjqs-2026-020441v1.20","doi-asserted-by":"publisher","DOI":"10.1080\/17439760.2016.1262613"},{"key":"2026091608200435000_bmjqs-2026-020441v1.21","unstructured":"Gwet KL . Handbook of Inter-Rater Reliability: The Definitive Guide to Measuring the Extent of Agreement among Raters: Advanced Analytics. LLC, 2014."},{"key":"2026091608200435000_bmjqs-2026-020441v1.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-020-0912-8","article-title":"Comparison of different rating scales for the use in Delphi studies: different scales lead to different consensus and show different test-retest reliability","volume":"20","author":"Lange","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"2026091608200435000_bmjqs-2026-020441v1.23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/2192568220911648","article-title":"Kappa and Beyond: Is There Agreement?","volume":"10","author":"Dettori","year":"2020","journal-title":"Global Spine J"},{"key":"2026091608200435000_bmjqs-2026-020441v1.24","article-title":"Audit and feedback: effects on professional practice","volume":"3","author":"Ivers","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"2026091608200435000_bmjqs-2026-020441v1.25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.eurger.2013.06.006","article-title":"Potentiality of STOPP\/START criteria used in primary care to effectively change inappropriate prescribing in elderly patients","volume":"4","author":"Mart\u00edn Lesende","year":"2013","journal-title":"Eur Geriatr Med"},{"key":"2026091608200435000_bmjqs-2026-020441v1.26","first-page":"1","article-title":"Differences in the Management and Use of Health Services in Australia Using Publicly Available Data: Comparisons between New South Wales and Victoria","volume":"20","author":"Martins","year":"2025","journal-title":"APJHM"},{"key":"2026091608200435000_bmjqs-2026-020441v1.27","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1016\/j.arthro.2025.03.038","article-title":"Guidelines for Designing and Conducting Delphi Consensus Studies: An Expert Consensus Delphi Study","volume":"41","author":"Hohmann","year":"2025","journal-title":"Arthroscopy"}],"container-title":["BMJ Quality &amp; Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjqs-2026-020441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:20:20Z","timestamp":1789572020000},"score":1,"resource":{"primary":{"URL":"https:\/\/qualitysafety.bmj.com\/lookup\/doi\/10.1136\/bmjqs-2026-020441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":27,"alternative-id":["10.1136\/bmjqs-2026-020441"],"URL":"https:\/\/doi.org\/10.1136\/bmjqs-2026-020441","relation":{},"ISSN":["2044-5415","2044-5423"],"issn-type":[{"value":"2044-5415","type":"print"},{"value":"2044-5423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}